3 chapters across the catalog
US Vaccine Donation Strategy and Booster Efficacy Data
The Biden administration awarded Pfizer a $2 billion contract modification for 300 million additional vaccine doses intended for international donation to low-income countries. This comes as U.S. health officials emphasize the efficacy of the third dose in preventing hospitalization while downplaying the immediate necessity of a fourth dose for the general population.
Dr. Peter Hotez criticized the Biden administration for a lack of leadership in vaccinating the global population, specifically the African continent. Hotez announced that the Texas Children's Center for Vaccine Development is collaborating with Biological E in India to release a new vaccine for emergency use.
An anonymous report from a regional hospital in Oregon indicates that while ICU capacity is reported at 89%, the facility is not overwhelmed. The report suggests that hospital administrators prefer high occupancy rates for financial reasons and that bed counts are flexible. The data highlights a discrepancy between official "high risk" designations and the actual number of symptomatic patients.
